Status:
COMPLETED
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Physiological Effect of Drugs
Morphine
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to show that the effect of 3% 2-chloroprocaine prior to epidural morphine administration will be not inferior to the effect of epidural 2% lidocaine with 1:200,000 epineph...
Eligibility Criteria
Inclusion
- pregnant patients
- live singleton pregnancy
Exclusion
- BMI \>40
- obstructive sleep apnea
- drug abuse
- chronic pain
- chronic opioid use
- nonfunctioning epidural
Key Trial Info
Start Date :
May 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04369950
Start Date
May 11 2020
End Date
July 11 2021
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030